Polypharmacy in the Elderly

@article{Sergi2011PolypharmacyIT,
  title={Polypharmacy in the Elderly},
  author={Giuseppe Sergi and Marina De Rui and Silvia Sarti and Enzo Manzato},
  journal={Drugs \& Aging},
  year={2011},
  volume={28},
  pages={509-518}
}
Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, particularly among people aged >65 years. The main reasons for polypharmacy are longer life expectancy, co-morbidity and the implementation of evidence-based clinical practice guidelines. However, polypharmacy also has important negative consequences, such as a higher risk of adverse drug reactions and a decline in medication efficacy because of reduced compliance.Comprehensive… Expand
IL PUNTO DI VISTA DEL GERIATRA The geriatrician's point of view
TLDR
Comprehensive geriatric assessment (CGa) has proved effective in reducing the number of prescriptions and daily drug doses for patients as a result of unnecessary or inappropriate medications being discontinued and has demonstrated the ability to optimize the treatment by increasing thenumber of drugs taken in some cases because it identified under-treated diseases. Expand
Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention
TLDR
The results reinforce the need for the implementation of pharmaceutical care services to institutionalized elderly, necessary to improve medicines efficacy and safety, better clinical outcomes and cost reduction. Expand
Clinical pharmacology of old age
TLDR
New aspects that have emerged in recent years: appropriate monitoring of drug adherence and the introduction of Big Data analysis in advancing geriatric pharmacology are selected to highlight. Expand
Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment
TLDR
Polypharmacy, a condition that may lead to many potential detrimental outcomes in older diabetic subjects, was significantly associated with some risk factors that may be useful to identify subjects at risk. Expand
P OLYPHARMACY AMONG NURSING HOME RESIDENTS IN LOLLAND-CAN THE PHARMACOTHERAPY BE RATIONALIZED BY MEDICATION REVIEWS ?
Polypharmacy, the consumption of more concomitant drugs, increases the risk of drug related problems, like ADRs. Age is known to predispose to polypharmacy as the number of chronic diseases andExpand
Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan
TLDR
Potential DDIs in outpatients can be reduced by minimizing the number of drugs prescribed following careful consideration of both their benefits and risks, particularly in the aging population. Expand
Comorbidity and polypharmacy in patients with breast cancer
TLDR
The frequency of comorbidity and polypharmacy in patients with breast cancer and between the elderly and non-elderly participants are determined to raise awareness in the literature and for the effectiveness of cancer treatment, importance in geriatric population, attention to drug–drug interaction, should be considered during clinical practice. Expand
Deprescribing: An Approach to Reducing Polypharmacy in Nursing Home Residents
TLDR
The challenges associated with deprescribing, the ethical and clinical uncertainty that can exist in the indefinite use of some medications, and the guidelines available to help clinicians are discussed. Expand
Development of geriatric syndromes after taking countermeasures for polypharmacy: an overlooked issue of quitting semiregular single-dose medicine
TLDR
An elderly woman on polypharmacy who developed appetite loss, general fatigue and muscle weakness mainly from secondary adrenal insufficiency caused by quitting one semiregular single-dose medicine is reported. Expand
The relationship between common geriatric syndromes and potentially inappropriate medication use among older adults
TLDR
The results of this study suggest that PIM use is independently associated with presence of polypharmacy, malnutrition, depression, falls and dementia in older outpatients. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people.
TLDR
Application of the geriatric-palliative methodology in the disabled elderly enables simultaneous discontinuation of several medications and yields a number of benefits: reduction in mortality rates and referrals to acute care facilities, lower costs, and improved quality of living. Expand
Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.
TLDR
It is feasible to decrease medication burden in community-dwelling elderly patients and this tool would be suitable for larger randomized controlled trials in different clinical settings. Expand
Polypharmacy and falls in the middle age and elderly population.
TLDR
Fall risk is associated with the use of polypharmacy, but only when at least one established fall risk-increasing drug was part of the daily regimen. Expand
Patterns of Drug Use and Factors Associated with Polypharmacy and Excessive Polypharmacy in Elderly Persons
TLDR
The study indicates that the factors associated with PP and EPP are not uniform, while poor self-reported health and several specific disease states were associated with both PP andEPP. Expand
Polypharmacy in elderly patients at discharge from the acute care hospital
TLDR
Hospitalization increases drug prescription at discharge in elderly patients, and efforts are needed to identify the determinants and to assess the quality of this prescription practice, with the final aim of contrasting polypharmacy. Expand
Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
TLDR
A positive correlation between the use of >/=9 different scheduled medications and ADRs was found among these geriatric nursing home residents. Expand
Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008
TLDR
The prevalence of polyPHarmacy and excessive polypharmacy, as well as the mean number of dispensed drugs per individual, increased year-by-year in Sweden 2005-2008. Expand
Effects of Medication Assessment as Part of a Comprehensive Geriatric Assessment on Drug Use over a 1-Year Period
TLDR
Drug intervention as part of a CGA can be used to rationalize the drug therapy of a patient, however, its effectiveness is subsequently partly counteracted by other physicians working in the healthcare system. Expand
Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.
TLDR
The number of DRPs per patient was linearly related to the number of drugs used on admission, and to set a strict cut-off to identify polypharmacy and declare that using more than this number of drug represents a potential risk for occurrence ofDRPs, is of limited value when assessing DRPs in a clinical setting. Expand
Polypharmacy Correlates With Increased Risk for Hip Fracture in the Elderly: A Population-Based Study
TLDR
It is concluded that the risk of hip fracture in older people increases with the number of medications used, especially in women, and age interacts with the daily medications for the risk for hip fracture. Expand
...
1
2
3
4
5
...